Filing Details
- Accession Number:
- 0001171843-17-006236
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-24 16:05:24
- Reporting Period:
- 2017-10-20
- Accepted Time:
- 2017-10-24 16:05:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 898437 | Anika Therapeutics Inc. | ANIK | Surgical & Medical Instruments & Apparatus (3841) | 043145961 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1244298 | H Charles Sherwood | 32 Wiggins Avenue Bedford MA 01730 | Ceo And Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-10-20 | 5,991 | $60.04 | 158,297 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-10-23 | 22,228 | $60.06 | 136,069 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- On October 20, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 5,991 shares in multiple trades ranging from $60.00 to $60.13. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- On October 23, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 22,228 shares in multiple trades ranging from $60.00 to $60.22. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
